eye care

Showing 10 posts of 10 posts found.


J&J’s antihistamine-releasing contact lens shows promise in Phase 3 trials

March 28, 2019
Research and Development J&J, JJ, eye care, pharma

Johnson and Johnson has unveiled new Phase 3 data on its antihistamine-releasing contact lens, showing that the investigational product led …


Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx

February 1, 2019
Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma

In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …


Novartis eyecare unit Alcon to set up new HQ in Geneva, Switzerland

September 11, 2018
Manufacturing and Production Alcon, Novartis, eye care, pharma

Alcon, the eyecare unit of Novartis, is set to move to a new home next year, after its parent company …

Novartis spins off Alcon as CEO focuses drug search

June 29, 2018
Medical Communications, Sales and Marketing Alcon, Novartis, eye care, pharma

Novartis has announced a plan to spinoff Alcon – its eye care division – into a separately-traded standalone company.Novartis has …


Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016
Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …


Allergan breaks ground on $200 million expansion at Texas site

April 26, 2016
Manufacturing and Production Allergan, doubling, expansion, eye care, facility, investment, manufacturing, size, texas, waco

Allergan (NYSE: AGN) has broken ground on a $200 million expansion at its manufacturing facility in Waco, Texas. The expansion …

Merck acquires eyecare specialist Inspire

April 6, 2011
Research and Development, Sales and Marketing Inspire, Merck, eye care

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …

Eye treatment could be commercial breakthrough for ThromboGenics

September 1, 2010
Research and Development ThromboGenics, eye care, microplasmin

Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …

Novartis to acquire majority stake in Alcon

January 5, 2010
Sales and Marketing Alcon, Novartis, eye care

Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …

Latest content